...
首页> 外文期刊>Ultrasound in Medicine and Biology >MICROBUBBLES, NANODROPLETS AND GAS-STABILIZING SOLID PARTICLES FOR ULTRASOUND-MEDIATED EXTRAVASATION OF UNENCAPSULATED DRUGS: AN EXPOSURE PARAMETER OPTIMIZATION STUDY
【24h】

MICROBUBBLES, NANODROPLETS AND GAS-STABILIZING SOLID PARTICLES FOR ULTRASOUND-MEDIATED EXTRAVASATION OF UNENCAPSULATED DRUGS: AN EXPOSURE PARAMETER OPTIMIZATION STUDY

机译:用于超声介导的未封装药物的微泡,纳米轧件和气体稳定固体颗粒:暴露参数优化研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ultrasound-induced cavitation has been proposed as a strategy to tackle the challenge of inadequate extravasation, penetration and distribution of therapeutics into tumours. Here, the ability of microbubbles, droplets and solid gas-trapping particles to facilitate mass transport and extravasation of a model therapeutic agent following ultrasound-induced cavitation is investigated. Significant extravasation and penetration depths on the order of millimetres are achieved with all three agents, including the range of pressures and frequencies achievable with existing clinical ultrasound systems. Deeper but highly directional extravasation was achieved with frequencies of 1.6 and 3.3 MHz compared with 0.5 MHz. Increased extravasation was observed with increasing pulse length and exposure time, while an inverse relationship is observed with pulse repetition frequency. No significant cell death or any haemolytic activity in human blood was observed at clinically relevant concentrations for any of the agents. Overall, solid gas-trapping nanoparticles were found to enable the most extensive extravasation for the lowest input acoustic energy, followed by microbubbles and then droplets. The ability of these agents to produce sustained inertial cavitation activity whilst being small enough to follow the drug out of the circulation and into diseased tissue, combined with a good safety profile and the possibility of real-time monitoring, offers considerable potential for enhanced drug delivery of unmodified drugs in oncological and other biomedical applications. (C) 2019 Published by Elsevier Inc. on behalf of World Federation for Ultrasound in Medicine & Biology.
机译:已经提出了超声诱导的空化作为解决治疗方法不足,渗透和分布到肿瘤的挑战的策略。这里,研究了微泡,液滴和固体气体捕获颗粒的能力,以促进超声诱导的空化之后的质量传输和模型治疗剂的外渗。所有三种试剂都可以实现大约毫米的初步和渗透深度,包括现有临床超声系统可实现的压力范围和频率。与0.5 MHz相比,通过1.6和3.3 MHz的频率实现更深的但高度定向的外向。观察到脉冲长度和曝光时间增加增加的外渗,而用脉冲重复频率观察到逆关系。在临床相关浓度下,在任何药剂的临床相关浓度下观察到人血中没有显着的细胞死亡或任何溶血活性。总体而言,发现固体气体捕获纳米颗粒能够对最低输入声能量进行最广泛的外渗,其次是微泡,然后液滴。这些药剂产生持续惯性空化活性的能力,同时足够小,以遵循循环和患病组织的药物,与良好的安全性曲线合并,具有实时监测的可能性,提供了相当大的药物交付潜力未经修改的药物在肿瘤和其他生物医学应用中。 (c)2019年由elsevier Inc.发布的,代表世界医学与生物学的超声联联联合会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号